Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Cytokinetics Wins FDA Nod For Heart Drug Myqorzo
↗
December 22, 2025
Via
Benzinga
Exposures
Product Safety
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Tickers
ARQT
ARWR
CDTX
JNJ
JPM
KURA
Exposures
Economy
Intellectual Property
Interest Rates
The Incretin Empire: Eli Lilly’s (LLY) Path to a $1 Trillion Market Cap and Beyond
December 22, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
Tickers
BLK
LLY
MS
MSFT
NVDA
NVO
Exposures
Intellectual Property
Interest Rates
Product Safety
How to prep your car for safer winter driving
December 19, 2025
Via
Brandpoint
Topics
Product Recall
Exposures
Legal
Product Safety
Pantry Powerhouse: A Deep-Dive into General Mills (GIS) in the Age of GLP-1 and Pet Humanization
December 22, 2025
Via
PredictStreet
Topics
Earnings
Economy
Tickers
GIS
KHC
Exposures
Economy
Financial
Interest Rates
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
December 22, 2025
Via
PredictStreet
Topics
Earnings
Initial Public Offering
Intellectual Property
Tickers
BNTX
GSK
MRK
MRNA
PFE
VRTX
Exposures
COVID-19
Financial
Intellectual Property
FDA Flags Deadly Risks, AstraZeneca Pulls Andexxa From US Market
↗
December 22, 2025
Via
Benzinga
Exposures
Product Safety
CCHR: FDA Oversight Failure Driving National Crisis in Psychiatric Drug Harm
December 22, 2025
Via
Send2Press
Exposures
Product Safety
Science-Based Migraine Education: WhatAreMigraines.com Platform Announced
December 20, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
The 2 Riskiest Stocks Investors Are Betting On With Over 300% Upside
December 20, 2025
Via
Barchart.com
Exposures
Product Safety
Don Herner: The Maverick Designer Refusing to Build Ordinary Cars
December 20, 2025
Via
24-7 Press Release
Topics
Intellectual Property
Product Recall
Tickers
GM
HMC
Exposures
Intellectual Property
Legal
Product Safety
Ford Recalls Over 270,000 Electric And Hybrid Vehicles Over Potential Roll-Away Risk
↗
December 20, 2025
Via
Benzinga
Topics
Product Recall
Tickers
F
Exposures
Legal
Product Safety
The Hot Years Magazine Releases Special Issue Focused on Hot Flashes
December 19, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious?
↗
December 19, 2025
Via
Stocktwits
Tickers
CYTK
IWMW
VFMO
Exposures
Product Safety
Failure Not an Option Launches: New Cold War Memoir Traces Bob Hicks Journey from Somerset Farm Boy to Senior Federal Law Enforcement Officer
December 19, 2025
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’
↗
December 19, 2025
Via
Stocktwits
Tickers
EAOR
IRON
IWMW
Exposures
Product Safety
The Vertical AI Revolution: Why SoundHound, BigBear, and Tempus AI are Defining the Market in Late 2025
December 19, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Tickers
BBAI
GOOGL
MSFT
NVDA
SOUN
TEM
Exposures
Artificial Intelligence
Economy
Product Safety
Cassava Sciences Stock On Track For Worst Day In About 9 Months — What’s Driving Today’s Selloff?
↗
December 19, 2025
Via
Stocktwits
Tickers
DFAS
SAVA
VTI
Exposures
Product Safety
FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold
↗
December 19, 2025
Via
Benzinga
Exposures
Product Safety
The Great Biotech Re-Shoring: Seres Therapeutics and the New Commodity-Driven Era
December 19, 2025
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
Tickers
AMGN
LLY
MCRB
NSRGY
Exposures
Economy
Financial
Intellectual Property
Why Cytokinetics CEO Is Optimistic As FDA Deadline On Aficamten Looms
↗
December 19, 2025
Via
Investor's Business Daily
Exposures
Product Safety
Altimmune Stock Soars Over 10% Premarket On Positive Mid-Stage Data For Liver Disease Treatment Drug
↗
December 19, 2025
Via
Stocktwits
Tickers
ALT
Exposures
Product Safety
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Ignore
December 18, 2025
Via
StockStory
Tickers
DXCM
GOLF
ODFL
Exposures
Product Safety
Morris R. Heney Launches Travels with Rina
December 18, 2025
Via
AB Newswire
Topics
Bonds
Product Recall
Exposures
Debt Markets
Legal
Product Safety
Agentic AI in Healthcare: The Next Frontier Beyond Generative AI
December 18, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Tickers
IBM
Exposures
Artificial Intelligence
Product Safety
Novo Nordisk Files FDA Application For Weekly Combination Obesity Shot
↗
December 18, 2025
Via
Benzinga
Exposures
Product Safety
FDA Approves J&J's New 5-Minute Injection For Lung Cancer
↗
December 18, 2025
Via
Benzinga
Tickers
JNJ
Exposures
Product Safety
Takeda's Once-Daily Psoriasis Pill Hits Phase 3 Goals, Beats Amgen's Drug
↗
December 18, 2025
Via
Benzinga
Exposures
Product Safety
Eli Lilly’s Oral Obesity Drug Passes Maintenance Test After Wegovy, Zepbound — Wall Street Flags Win For Viking Therapeutics
↗
December 18, 2025
Via
Stocktwits
Tickers
JGRO
LLY
QUSA
VKTX
Exposures
Product Safety
Merck Cholesterol, Cancer Drugs May Enter FDA Fast-Track Program: Report
↗
December 18, 2025
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.